Open Access<p>Generic Tacrolimus (Tacrobell<sup>®</sup>) Shows Comparable Outcomes to Brand-Name Tacrolimus in the Long-Term Period After Adult Deceased Donor Liver Transplantation</p>
Author(s) -
Jong Man Kim,
GyuSeong Choi,
Suk-Koo Lee
Publication year - 2019
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s229114
Subject(s) - tacrolimus , medicine , liver transplantation , creatinine , renal function , transplantation , gastroenterology , urology , surgery
Generic tacrolimus (Tacrobell ® ) is commonly used in liver transplant patients in Korea. No previous studies have assessed the long-term efficacy and safety of generic tacrolimus for adult deceased donor liver transplantation (DDLT) patients. The aim of the present study was to evaluate the long-term efficacy and safety of generic tacrolimus compared to brand-name tacrolimus (Prograf ® ) in adult DDLT recipients.